Life Bio, Forge to develop gene therapies for aging-linked diseases
Life Biosciences has announced a cGMP manufacturing collaboration with Forge Biologics to develop new gene therapies to treat aging-related diseases.
Stay updated with breaking news from Ignition Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Life Biosciences has announced a cGMP manufacturing collaboration with Forge Biologics to develop new gene therapies to treat aging-related diseases.
The partnership is focused on addressing aging-related diseases, including its lead program targeting ophthalmic indications.